Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
22 results
D3.308 - Kounis Syndrome: the allergic myocardial infarction
D3.313 - Recurrent Anaphylaxis with Elevated Baseline Tryptase Revealing Hereditary Alpha-Tryptasemia with Mast Cell Activation
D3.318 - Evaluation of Clinical Predictors and Serum Tryptase Levels in Systemic Mastocytosis
D3.319 - Clinical Data of Drug Induced Anaphylaxis according to the standardized European Anaphylaxis Registry (NORA)
D3.320 - Anaphylaxis by Chlorhexidine: A case series
D3.321 - Cardiac arrest after Iodixanol: a case of non-IgE mediated mast cell activation
D3.307 - Chlorhexidine-triggered anaphylaxis in a child with multisystem allergy and sickle cell disease: a diagnostic pitfall
D3.465 - Climate Change Anxiety Scale (HAES-13) in assessing the emotional impact of extreme weather events
D3.466 - Quantitative assessment of environmental exposure to Der p1, Der p 2 and Der p 23 in European and South African house dust samples
D3.471 - Invisible Ventilation Gaps: Continuous Low-Cost Indoor Air Quality Monitoring in a Northern Portuguese Hospital
D3.469 - Interaction between Meteorological Variables and Atmospheric Pollutants in the Dynamics of Alternaria Spores in Bragança, Portugal
D3.472 - Innovative Environmental Allergen Mitigation Using Probiotic-Treated Carpets
D3.473 - Symptom burden and sensitization patterns in allergic rhinitis: real-world data
D3.474 - Non-IgE-mediated rhinitis in sub-Saharan Africa: an underdiagnosed condition?
- D3.519 - Post-COVID-19 Reshaping of Molecular IgE Sensitization Profiles to Seasonal and Indoor Allergens
D3.521 - Dermatologic adverse effects of COVID-19 vaccination
- D3.522 - Post-Vaccination SARS-CoV-2 Infections: Evidence, Severity, and Outcomes
D3.523 - Early childhood: a risk predictor for post-COVID-19 pulmonary sequelae in children
- D3.524 - Clinical use of procalcitonin and IL-6 in diagnosis of bacterial superinfection in COVID-19
- D3.525 - One- year hospital readmission after pediatric COVID- 19 hospitalization: a single- center cohort study
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download